Concepedia

Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality

John F. Carpenter, Theodore W. Randolph, Wim Jiskoot, Daan J.A. Crommelin, C. Russell Middaugh, Gerhard Winter, Ying‐Xin Fan, Susan Kirshner, Daniela Verthelyi, Steven Kozlowski,

Journal of Pharmaceutical Sciences · 2008 · 588 citations · 6 references

DOIFull text

Open access

Concepts

References

6

IgG particle formation during filling pump operation: A case study of heterogeneous nucleation on stainless steel nanoparticles

Anil K. Tyagi, Theodore W. Randolph, Aichun Dong et al. · Journal of Pharmaceutical Sciences · 2008 · 192 citations

, , +17

Structural Characterization and Immunogenicity in Wild-Type and Immune Tolerant Mice of Degraded Recombinant Human Interferon Alpha2b

Suzanne Hermeling, L Aranha, J Damen et al. · Pharmaceutical Research · 2005 · 144 citations · Full text

, , +10

Heterogeneous Nucleation-Controlled Particulate Formation of Recombinant Human Platelet-Activating Factor Acetylhydrolase in Pharmaceutical Formulation

Eva Y., Joachim L. Weickmann, John F. Carpenter et al. · Journal of Pharmaceutical Sciences · 2004 · 111 citations

, , +14

Stabilization of a hydrophobic recombinant cytokine by human serum albumin

Andrea Hawe · Journal of Pharmaceutical Sciences · 2007 · 41 citations

, , +8

Acute and Long-Term Stability Studies of Deoxy Hemoglobin and Characterization of Ascorbate-Induced Modifications

Bruce A. Kerwin, Michael J. Akers, Izydor Apostoł et al. · Journal of Pharmaceutical Sciences · 1999 · 38 citations

, , +14